The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 25, 2019

Filed:

Jul. 15, 2016
Applicants:

Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Lianyungang, CN;

Lianyungang Runzhong Pharmaceutical Co., Ltd., Lianyungang, CN;

Centaurus Biopharma Co., Ltd., Beijing, CN;

Inventors:

Yan Zhu, Beijing, CN;

Na Zhao, Beijing, CN;

Xianxing Shang, Beijing, CN;

Yuandong Hu, Beijing, CN;

Yong Peng, Beijing, CN;

Hui Zhang, Beijing, CN;

Bo Liu, Beijing, CN;

Hong Luo, Beijing, CN;

Yongxin Han, Beijing, CN;

Ling Yang, Lianyungang, CN;

Hongjiang Xu, Lianyungang, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 403/02 (2006.01); C07D 403/04 (2006.01); A61K 31/506 (2006.01); C07D 413/04 (2006.01); A61P 35/00 (2006.01); A61K 31/5377 (2006.01);
U.S. Cl.
CPC ...
C07D 403/04 (2013.01); A61K 31/506 (2013.01); A61K 31/5377 (2013.01); A61P 35/00 (2018.01); C07D 413/04 (2013.01);
Abstract

The present disclosure relates to aniline pyrimidine derivatives or pharmaceutically acceptable salts thereof as EGFR inhibitors, specifically relates to compounds represented by formula (I) or pharmaceutically acceptable salts, pharmaceutical compositions, the method and uses thereof for treating EGFR mediated diseases.


Find Patent Forward Citations

Loading…